Shares of Digirad Corp. (NASDAQ:DRAD) were up 4% on Tuesday . The company traded as high as $5.26 and last traded at $5.23, with a volume of 62,816 shares changing hands. The stock had previously closed at $5.03.

A number of analysts have recently weighed in on DRAD shares. Sidoti started coverage on Digirad Corp. in a research report on Wednesday, May 25th. They set a “buy” rating and a $8.00 target price for the company. Zacks Investment Research upgraded Digirad Corp. from a “hold” rating to a “buy” rating and set a $6.00 price objective for the company in a research report on Tuesday, May 3rd. Finally, B. Riley restated a “buy” rating and set a $7.00 price objective on shares of Digirad Corp. in a research report on Sunday, May 1st.

The firm has a 50 day moving average of $5.43 and a 200 day moving average of $5.23. The firm has a market capitalization of $102.35 million and a price-to-earnings ratio of 3.21.

Digirad Corp. (NASDAQ:DRAD) last issued its quarterly earnings results on Thursday, July 28th. The company reported $0.09 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.09. Analysts predict that Digirad Corp. will post $0.31 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, August 29th. Shareholders of record on Wednesday, August 17th will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 3.82%. The ex-dividend date is Monday, August 15th.

In other news, Director Jeffrey E. Eberwein bought 28,482 shares of the firm’s stock in a transaction on Friday, August 19th. The stock was acquired at an average cost of $5.00 per share, with a total value of $142,410.00. Following the completion of the transaction, the director now directly owns 12,500 shares of the company’s stock, valued at approximately $62,500. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeffrey E. Eberwein bought 18,394 shares of the firm’s stock in a transaction on Monday, August 15th. The stock was purchased at an average cost of $5.00 per share, with a total value of $91,970.00. Following the completion of the transaction, the director now directly owns 12,500 shares of the company’s stock, valued at $62,500. The disclosure for this purchase can be found here.

Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.